Авторы

  • Исроилов А.А., Каримов Х.Я., Маткаримова Д.С.

Ключевые слова:

множественная миелома, гематологические показатели, гемоглобин, тромбоциты, лейкоциты, скорость оседания эритроцитов.

Библиографические ссылки

Cowan A. J. et al. Diagnosis and management of multiple myeloma: a review //Jama. – 2022. – Т. 327. – №. 5. – С. 464-477.

Chang H. H., Liou Y. S., Sun D. S. Hematopoietic stem cell mobilization //Tzu Chi Medical Journal. – 2022. – Т. 34. – №. 3. – С. 270-275.

Elsabah H. et al. Real-world evidence of epidemiological trends, clinical presentation, and prognostic outcomes of multiple myeloma (2007-2021) //Frontiers in Medicine. – 2024. – Т. 11. – С. 1338552.

Huang J. et al. The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends //The Lancet Haematology. – 2022. – Т. 9. – №. 9. – С. e670-e677/

Isroilov A.А., Karimov Kh. Ya., Matkarimova D. S., Boboev K.T., Makhamadaliyeva G. Z. Analysis of efficiency of multiple myeloma therapy by the method of translation of autologic hemopoetic stem cells in Uzbekistan. Journal of Xi’an Shiyou University, Natural Science Edition, volume 16 issue 10, Р. 175-179.

Luo Q. et al. Multiple myeloma incidence, mortality, and prevalence estimates and projections, Australia, 1982–2043: a statistical modelling study //Medical Journal of Australia. – 2024. – Т. 221. – №. 2. – С. 103-110.

Mafra A. et al. The global multiple myeloma incidence and mortality burden in 2022 and predictions for 2045 //JNCI: Journal of the National Cancer Institute. – 2025. – Т. 117. – №. 5. – С. 907-914.

Moreau P. et al. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group //The Lancet Oncology. – 2021. – Т. 22. – №. 3. – С. e105-e118.

Rodriguez-Otero P., Paiva B., San-Miguel J. F. Roadmap to cure multiple myeloma //Cancer treatment reviews. – 2021. – Т. 100. – С. 102284.